BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16866611)

  • 1. Methods of evaluating immunotoxicity.
    Descotes J
    Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):249-59. PubMed ID: 16866611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotoxicology: role in the safety assessment of drugs.
    Descotes J
    Drug Saf; 2005; 28(2):127-36. PubMed ID: 15691223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of immunotoxicity in safety assessment: a medical toxicologist's perspective.
    Descotes J
    Toxicol Lett; 2004 Apr; 149(1-3):103-8. PubMed ID: 15093254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotoxicity and immunogenicity of biopharmaceuticals: design concepts and safety assessment.
    Bhogal N
    Curr Drug Saf; 2010 Oct; 5(4):293-307. PubMed ID: 20615176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotoxicity of monoclonal antibodies.
    Descotes J
    MAbs; 2009; 1(2):104-11. PubMed ID: 20061816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing human biologicals in animal host resistance models.
    Burleson GR; Burleson FG
    J Immunotoxicol; 2008 Jan; 5(1):23-31. PubMed ID: 18382855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxicology: opportunities for non-animal test development.
    Corsini E; Roggen EL
    Altern Lab Anim; 2009 Sep; 37(4):387-97. PubMed ID: 19807211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs.
    Piccotti JR; Lebrec HN; Evans E; Herzyk DJ; Hastings KL; Burns-Naas LA; Gourley IS; Wierda D; Kawabata TT
    J Immunotoxicol; 2009 Mar; 6(1):1-10. PubMed ID: 19519157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotoxicology testing: past and future.
    Luster MI; Gerberick GF
    Methods Mol Biol; 2010; 598():3-13. PubMed ID: 19967502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and future of in vitro immunotoxicology in drug development.
    Galbiati V; Mitjans M; Corsini E
    J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety immunopharmacology: evaluation of the adverse potential of pharmaceuticals on the immune system.
    Descotes J
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):79-83. PubMed ID: 22587937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro testing for direct immunotoxicity: state of the art.
    Lankveld DP; Van Loveren H; Baken KA; Vandebriel RJ
    Methods Mol Biol; 2010; 598():401-23. PubMed ID: 19967527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of contact hypersensitivity in immunotoxicity testing.
    Descotes J
    Methods Mol Biol; 2010; 598():233-9. PubMed ID: 19967518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
    Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of validation study of assessment of direct immunotoxicity in the rat. The ICICIS Group Investigators. International Collaborative Immunotoxicity Study.
    Toxicology; 1998 Feb; 125(2-3):183-201. PubMed ID: 9570332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immunotoxic effects of chemicals and assessment of their relevance to man.
    Trizio D; Basketter DA; Botham PA; Graepel PH; Lambré C; Magda SJ; Pal TM; Riley AJ; Ronneberger H; Van Sittert NJ
    Food Chem Toxicol; 1988 Jun; 26(6):527-39. PubMed ID: 3049276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Immunotoxicology.
    Peyton Myers L
    Methods Mol Biol; 2018; 1803():15-26. PubMed ID: 29882130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxicity testing: an economical multiple-assay approach.
    Exon JH; Koller LD; Talcott PA; O'Reilly CA; Henningsen GM
    Fundam Appl Toxicol; 1986 Oct; 7(3):387-97. PubMed ID: 3491011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a Candida albicans delayed-type hypersensitivity (DTH) model in female juvenile rats for use in immunotoxicity assessments.
    Collinge M; Thorn M; Peachee V; White K
    J Immunotoxicol; 2013; 10(4):341-8. PubMed ID: 23282408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of xenobiotics for direct immunotoxicity in an animal study.
    De Jong WH; Van Loveren H
    Methods; 2007 Jan; 41(1):3-8. PubMed ID: 17161297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.